Delivery Order SPE2DB22D2206-SPE2DB25FHW65
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order for Copaxone 40 mg/ml syringes valued at $1,041.36 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. This competitive, firm fixed-price contract has an ultimate completion date of August 20, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999 and extends through December 2026. The pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is a delivery order for COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Copaxone 40 mg/ml syringes under a firm fixed-price contract valued at $7,950.72. This is a non-set-aside competitive award with an ultimate completion date of August 26, 2025, and performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Copaxone is a disease-modifying therapy used in the treatment of multiple sclerosis, and this delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The $2,010.87 order is for the drug Copaxone 40 mg/ml in syringes, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor. This order is issued under an indefinite delivery contract (IDC) awarded by DLA to...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $181,775.17, is for the delivery of Copaxone 20mg 1mL 30s, a multiple sclerosis medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 19, 2015. This award is not designated as a set-aside contract....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,215.36, is for the supply of COPAXONE 40 MG/ML syringes, a specialty medication used to treat multiple sclerosis. The contract has a fixed-price delivery order structure and an ultimate completion date of August 26, 2024. AmerisourceBergen holds a larger $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,176.33 firm fixed-price contract is for the supply of COPAXONE 40 MG/ML syringes, a medication used to treat multiple sclerosis. The contract has an ultimate completion date of May 5, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle...
- This federal contract award, valued at $1,448.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on March 12, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $5,178.94 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply COPAXONE 40 MG/ML SYRINGEML. Performance will take place in Conshohocken, Pennsylvania under a one day period from September 28 through 29, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies for...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,245.16 contract is for the delivery of COPAXONE 40 MG/ML syringes to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is...